Skip to main content
Log in

Dimethyltryptamine levels in blood of schizophrenic patients and control subjects

  • Human Pharmacology
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

A gas chromatographic-mass spectrometric determination of blood N,N-dimethyltryptamine in normal controls and schizophrenic patients was carried out with a sensitivity limit of 0.05 ng/ml whole blood. Although the results appear to suggest that the mean DMT level was higher in the total patient group, those patients with acute psychosis, female patients and patients with suspiciousness scores on the BPRS of 4 or over, the differences were not statistically significant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aghajanian, G. K., Foote, W. E., Sheard, M. H.: Action of psychotogenic drugs in single raphe neurons. J. Pharmacol. exp. Ther. 171, 178–187 (1970)

    Google Scholar 

  • Bidder, T. G., Mandel, L. R., Ahn, H. S., Walker, R. W., Vanden-Heuvel, W. J. A.: Blood and urinary dimethyltryptamine concentrations in acute psychotic disorders. Lancet 1974I, 165

  • Forrest, F. M., Forrest, Irene S., Mason, A. S.: Review of rapid urine tests for phenothiazine and related drugs. Amer. J. Psychiat. 118, 300–307 (1961)

    Google Scholar 

  • Lipinski, J. F., Mandel, L. R., Ahn, H. S., VandenHeuvel, W. J. A., Walker, R. W.: Blood dimethyltryptamine concentrations in psychotic disorders. Biol. Psychiat. 9, 89–91 (1974)

    Google Scholar 

  • Mandel, L. R.: Dimethyltryptamine: Its biosynthesis and possible role in mental disease. In: Neurotransmitter balance and behavior, E. F. Domino and J. Davis, eds., Ann Arbor, Michigan: Edward Brothers (in press, 1976)

    Google Scholar 

  • Walker, R. W., Ahn, H. S., Albers-Schonberg, G., Mandel, L. R., VandenHeuvel, W. J. A.: Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma. Biochem. Med. 8, 105–113 (1973)

    Google Scholar 

  • Wyatt, R. J., Gillin, J. C., Kaplan, J., Stillman, R., Mandel, L. R., Ahn, H. S., VandenHeuvel, W. J. A., Walker, R. W.: N,N-dimethyltryptamine: A possible relationship to schizophrenia. In: Advances in biochemical psychopharmacology, vol. II, pp. 299–313. New York: Raven Press 1974

    Google Scholar 

  • Wyatt, R. J., Mandel, L. R., Ahn, H. S., Walker, R. W., VandenHeuvel, W. J. A.: Gas chromatographic-mass spectrometric isotope dilution on N,N-dimethyltryptamine concentrations in normals and psychiatric patients. Psychopharmacologia (Berl.) 31, 265–270 (1973)

    Google Scholar 

  • Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Connelly, C. H., Pollin, W.: Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia. Science 179, 916–918 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angrist, B., Gershon, S., Sathananthan, G. et al. Dimethyltryptamine levels in blood of schizophrenic patients and control subjects. Psychopharmacology 47, 29–32 (1976). https://doi.org/10.1007/BF00428697

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00428697

Key words

Navigation